Envestnet Asset Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.17M | Sell |
18,315
-121
| -0.7% | -$7.76K | ﹤0.01% | 3180 |
|
2025
Q1 | $1.17M | Sell |
18,436
-1,258
| -6% | -$79.8K | ﹤0.01% | 3100 |
|
2024
Q4 | $1.31M | Sell |
19,694
-1,256
| -6% | -$83.6K | ﹤0.01% | 2979 |
|
2024
Q3 | $1.46M | Sell |
20,950
-3,497
| -14% | -$244K | ﹤0.01% | 2877 |
|
2024
Q2 | $1.58M | Buy |
24,447
+909
| +4% | +$58.9K | ﹤0.01% | 2739 |
|
2024
Q1 | $1.52M | Buy |
23,538
+6,084
| +35% | +$394K | ﹤0.01% | 2752 |
|
2023
Q4 | $1.15M | Buy |
17,454
+2,124
| +14% | +$140K | ﹤0.01% | 2840 |
|
2023
Q3 | $874K | Buy |
15,330
+651
| +4% | +$37.1K | ﹤0.01% | 2904 |
|
2023
Q2 | $900K | Buy |
14,679
+3,733
| +34% | +$229K | ﹤0.01% | 2826 |
|
2023
Q1 | $687K | Buy |
10,946
+2,518
| +30% | +$158K | ﹤0.01% | 2937 |
|
2022
Q4 | $535K | Sell |
8,428
-2,145
| -20% | -$136K | ﹤0.01% | 3059 |
|
2022
Q3 | $623K | Buy |
+10,573
| New | +$623K | ﹤0.01% | 2880 |
|
2022
Q1 | – | Sell |
-3,354
| Closed | -$239K | – | 4025 |
|
2021
Q4 | $239K | Buy |
+3,354
| New | +$239K | ﹤0.01% | 3555 |
|
2019
Q2 | – | Sell |
-5,095
| Closed | -$281K | – | 3064 |
|
2019
Q1 | $281K | Buy |
+5,095
| New | +$281K | ﹤0.01% | 2627 |
|
2018
Q3 | – | Sell |
-2,836
| Closed | -$155K | – | 2199 |
|
2018
Q2 | $155K | Hold |
2,836
| – | – | ﹤0.01% | 1794 |
|
2018
Q1 | $139K | Buy |
2,836
+143
| +5% | +$7.01K | ﹤0.01% | 1790 |
|
2017
Q4 | $127K | Buy |
2,693
+72
| +3% | +$3.4K | ﹤0.01% | 2022 |
|
2017
Q3 | $131K | Sell |
2,621
-987
| -27% | -$49.3K | ﹤0.01% | 1989 |
|
2017
Q2 | $165K | Buy |
3,608
+1,091
| +43% | +$49.9K | ﹤0.01% | 1939 |
|
2017
Q1 | $106K | Hold |
2,517
| – | – | ﹤0.01% | 2166 |
|
2016
Q4 | $98K | Buy |
2,517
+635
| +34% | +$24.7K | ﹤0.01% | 2188 |
|
2016
Q3 | $79K | Sell |
1,882
-2,955
| -61% | -$124K | ﹤0.01% | 2426 |
|
2016
Q2 | $179K | Buy |
4,837
+103
| +2% | +$3.81K | ﹤0.01% | 2156 |
|
2016
Q1 | $181K | Sell |
4,734
-13,594
| -74% | -$520K | ﹤0.01% | 2122 |
|
2015
Q4 | $926K | Sell |
18,328
-188
| -1% | -$9.5K | ﹤0.01% | 1326 |
|
2015
Q3 | $847K | Buy |
18,516
+3,019
| +19% | +$138K | ﹤0.01% | 1368 |
|
2015
Q2 | $904K | Sell |
15,497
-242
| -2% | -$14.1K | ﹤0.01% | 1443 |
|
2015
Q1 | $868K | Buy |
15,739
+419
| +3% | +$23.1K | ﹤0.01% | 1348 |
|
2014
Q4 | $769K | Sell |
15,320
-528
| -3% | -$26.5K | 0.01% | 593 |
|
2014
Q3 | $733K | Sell |
15,848
-2,816
| -15% | -$130K | 0.01% | 670 |
|
2014
Q2 | $816K | Sell |
18,664
-3,578
| -16% | -$156K | 0.01% | 618 |
|
2014
Q1 | $926K | Buy |
22,242
+665
| +3% | +$27.7K | 0.01% | 484 |
|
2013
Q4 | $799K | Buy |
21,577
+930
| +5% | +$34.4K | 0.01% | 502 |
|
2013
Q3 | $724K | Buy |
20,647
+12,842
| +165% | +$450K | 0.01% | 510 |
|
2013
Q2 | $225K | Buy |
+7,805
| New | +$225K | ﹤0.01% | 778 |
|